Approval · Notice of Compliance 9 · 2004
RATIO-AMCINONIDE: Notice of Compliance 9
Issued January 14, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9
- Date
- January 14, 2004
- Company
- Ratiopharm Inc.Ulm, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Topical corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RATIO-AMCINONIDE | 02247097 | Cancelled Post Market |
| RATIO-AMCINONIDE | 02247096 | Cancelled Post Market |
Medicinal ingredients
- AMCINONIDE 0.1 PER